首页> 外文期刊>International ophthalmology >Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.
【24h】

Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone.

机译:玻璃体内曲安奈德治疗后增生性糖尿病视网膜病变中视神经乳头新生血管的退化。玻璃体内曲安奈德后糖尿病性视盘新血管形成的回归。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study is to report the clinical outcome of a diabetic patient with optic nerve head neovascularization treated with an intravitreal injection of triamcinolone acetonide. A 52-year-old patient presented with clinically significant diffuse macular edema and optic nerve head neovascularization due to proliferative diabetic retinopathy in her right eye. Despite grid laser photocoagulation in the macular region macular edema progressed and visual acuity declined. The patient received a single intravitreal injection of 4 mg triamcinolone acetonide with topical anesthesia. After injection of triamcinolone acetonide visual acuity increased and macular edema decreased. Furthermore optic nerve head neovascularization had markedly regressed. No complication was observed during follow-up period. Intravitreal injection of triamcinolone acetonide may be useful for treatment of optic nerve head neovascularization in patients with proliferative diabetic retinopathy.
机译:这项研究的目的是报告玻璃体内注射曲安奈德治疗的患有视神经乳头新生血管的糖尿病患者的临床结果。一名52岁的患者因右眼增生性糖尿病性视网膜病而出现临床上显着的弥漫性黄斑水肿和视神经乳头新生血管。尽管使用栅格激光光凝治疗黄斑区,但黄斑水肿仍在发展,视力下降。患者接受局部麻醉的玻璃体内单次注射4 mg曲安奈德。注射曲安奈德后,视力增加,黄斑水肿减少。此外,视神经乳头的新血管形成已明显消退。在随访期间未观察到并发症。玻璃体内注射曲安奈德可能对增生性糖尿病视网膜病变患者的视神经乳头新生血管形成有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号